NIH-funded research R01 grant

Measuring brain oxygen metabolism in Alzheimer's disease using MRI

Official title: Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's disease

Funded at Weill Medical Coll of Cornell Univ · NIH-10933507 · Data updated 2026-11-12

This study is testing a new MRI method to measure how well the brain uses oxygen in people with Alzheimer's disease, making it easier and safer to track changes in brain function over time without the need for expensive and radioactive tests.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$806,332
NIH project number5R01AG080011-02
Project IDNIH-10933507 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or mild cognitive impairment.

Less likely to help

Patients with other forms of dementia or neurological disorders unrelated to Alzheimer's may not benefit from this research.

What this research studies

This research focuses on developing a new MRI-based technique to measure cerebral oxygen metabolism in patients with Alzheimer's disease (AD). Current methods like PET scans are limited due to their use of radioactive tracers and higher costs, making them impractical for regular monitoring. The study aims to create a more accessible and accurate method for assessing brain metabolism, which could help in tracking disease progression and evaluating treatment effects. By using advanced MRI techniques, the researchers hope to provide a clearer picture of how Alzheimer's affects brain function over time.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for diagnosing and monitoring Alzheimer's disease, ultimately enhancing patient care.

How similar studies have gone: While MRI techniques have been explored in various contexts, this specific approach to measuring cerebral oxygen metabolism in Alzheimer's disease is novel and has not been extensively tested.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Wang, Yi — Weill Medical Coll of Cornell Univ
  • Study coordinator: Wang, Yi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.